Tekrarlayan Gebelik Kayıplarının Etiyolojik ve Demografik Verilerinin İncelenmesi

Rai R, Regan L. Recurrent miscarriage. Lancet. 2006;368:601–11.

van den Berg MM, van Maarle MC, van Wely M, Goddijn M. Genetics of early miscarriage. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2012;1822(12):1951-9.

Kolte A, Bernardi L, Christiansen O, Quenby S, Farquharson R, Goddijn M, et al. Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Hum Reprod. 2014;30(3):495-8.

Karlı P. Abortus Sonuçlarının Retrospektif Değerlendirilmesi, İki Yıllık Deneyim. Adıyaman Üniversitesi Sağlık Bilimleri Derg. 2017;3(3):565-70.

Kovalevsky G, Gracia CR, Berlin JA, Sammel MD, Barnhart KT. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis. Archives of Internal Medicine. 2004;164(5):558-63.

Guideline on the management of recurrent pregnancy loss. 2017. https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Recurrent-pregnancy- loss.aspx Erişim tarihi: 05.09.2018.

Aksin Ş. Tekrarlayan gebelik kayıpları. Van Tıp Derg. 2017;24(4):410-4.

Kujovich JL. Thrombophilia and pregnancy complications. American Journal of Obstetrics and Gynecology. 2004;191(2):412-24.

Kutteh WH. Recurrent pregnancy loss: an update. Current Opinion in Obstetrics and Gynecology. 1999;11(5):435-9.

Clifford K, Rai R, Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod. 1997;12(2):387-9.

Laufer MR, Ecker JL, Hill JA. Pregnancy outcome following ultrasound- detected fetal cardiac activity in women with a history of multiple spontaneous abortions. Journal of the Society for Gynecologic Investigation. 1994;1(2):138-42.

Cabik DJ, Swingler R. Wardle PG, Regan L, Bacbos M, Forquharson RG, et al. Early prenatal. In: Risk pregnancy, managemet options. 4th. Ed (Cheff Edt: James D.) Saunders. 2011;57-160.

Coulam CB. Epidemiology of recurrent spontaneous abortion. American Journal of Reproductive Immunology. 1991;26(1):23-7.

Christiansen OB, Andersen A-MN, Bosch E, Daya S, Delves PJ, Hviid TV, et al. Evidence-based investigations and treatments of recurrent pregnancy loss. Fertility and Sterility. 2005;83(4):821-39.

Regan L, Rai R. Epidemiology and the medical causes of miscarriage. Best Practice & Research Clinical Obstetrics & Gynaecology. 2000;14(5):839-54.

Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. The Lancet. 2003;361(9361):901-8.

Cunningham FG, Gant N, Leveno KJ, Gilstrap L, Hauth J, Wenstrom K. Williams Obstetrics. New York : McGraw-Hill. 2001.

Crawford NM, Steiner AZ. Age-related infertility. Obstetrics and Gynecology Clinics. 2015;42(1):15-25.

Jauniaux E, Farquharson RG, Christiansen OB, Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 2006;21(9):2216-22.

The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage. April 2011. https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_17.pdf Son erişim tarihi: 18.10.2018.

Kolte A, Van Oppenraaij R, Quenby S, Farquharson R, Stephenson M, Goddijn M, et al. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage. Hum Reprod. 2014;29(5):931-7.

Paukku M, Tulppala M, Puolakkainen M, Anttila T, Paavonen J. Lack of association between serum antibodies to Chlamydia trachomatis and a history of recurrent pregnancy loss. Fertility and Sterility. 1999;72(3):427-30.

Cao X, Cui Y, Zhang X, Lou J, Zhou J, Wei R. The correlation of sperm morphology with unexplained recurrent spontaneous abortion: A systematic review and meta-analysis. Oncotarget. 2017;8(33):55646.

Jukic AM, Calafat AM, McConnaughey DR, Longnecker MP, Hoppin JA, Weinberg CR, et al. Urinary concentrations of phthalate metabolites and bisphenol A and associations with follicular-phase length, luteal-phase length, fecundability, and early pregnancy loss. Environmental Health Perspectives. 2015;124(3):321-8.

Wong LF, Schliep KC, Silver RM, Mumford SL, Perkins NJ, Ye A, et al. The effect of a very short interpregnancy interval and pregnancy outcomes following a previous pregnancy loss. American Journal of Obstetrics and Gynecology. 2015;212(3):375. e1-. e11.

Roberts C, Algert C, Ford J, Nippita T, Morris J. Association between interpregnancy interval and the risk of recurrent loss after a midtrimester loss. Hum Reprod. 2016:1-7.

Andersen A-MN, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2000;320(7251):1708- 12.

Hatasaka HH. Recurrent miscarriage: epidemiologic factors, definitions, and incidence. Clinical Obstetrics and Gynecology. 1994;37(3):625-34.

Heuser C, Dalton J, Macpherson C, Branch DW, Porter TF, Silver RM. Idiopathic recurrent pregnancy loss recurs at similar gestational ages. American Journal of Obstetrics and Gynecology. 2010;203(4):343. e1-. e5.

Tulandi T, Al-Fozan H. Definition and etiology of recurrent pregnancy loss. www uptodate com. Son erişim tarihi: 10.10.2018.

Stephenson M, Awartani K, Robinson W. Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case–control study. Hum Reprod. 2002;17(2):446-51.

Bianco K, Caughey AB, Shaffer BL, Davis R, Norton ME. History of miscarriage and increased incidence of fetal aneuploidy in subsequent pregnancy. Obstetrics & Gynecology. 2006;107(5):1098-102.

Braekeleer MD, Dao T-N. Cytogenetic studies in couples experiencing repeated pregnancy losses. Hum Reprod. 1990;5(5):519-28.

Lanasa MC, Hogge WA, Kubik CJ, Ness RB, Harger J, Nagel T, et al. A novel X chromosome–linked genetic cause of recurrent spontaneous abortion. American Journal of Obstetrics and Gynecology. 2001;185(3):563-8.

Drugan A, Greb A, Johnson MP, Krivchenia EL, Uhlmann WR, Moghissi KS, et al. Determinants of parental decisions to abort for chromosome abnormalities. Prenatal Diagnosis. 1990;10(8):483-90.

Simpson JL, Meyers CM, Martin AO, Elias S, Ober C. Translocations are infrequent among couples having repeated spontaneous abortions but no other abnormal pregnancies. Fertility and Sterility. 1989;51(5):811-4.

Byrne JL, Ward K. Genetic factors in recurrent abortion. Clinical Obstetrics and Gynecology. 1994;37(3):693-704.

Rubio C, Simon C, Vidal F, Rodrigo L, Pehlivan T, Remohi J, et al. Chromosomal abnormalities and embryo development in recurrent miscarriage couples. Hum Reprod. 2003;18(1):182-8.

Munné S, Sandalinas M, Magli C, Gianaroli L, Cohen J, Warburton D. Increased rate of aneuploid embryos in young women with previous aneuploid conceptions. Prenatal Diagnosis: Published in Affiliation With the International Society for Prenatal Diagnosis. 2004;24(8):638-43.

Pluchino N, Drakopoulos P, Wenger JM, Petignat P, Streuli I, Genazzani AR. Hormonal causes of recurrent pregnancy loss (RPL). Hormones (Athens). 2014;13(3):314-22.

Ogasawara M, Kajiura S, Katano K, Aoyama T, Aoki K. Are serum progesterone levels predictive of recurrent miscarriage in future pregnancies? Fertility and Sterility. 1997;68(5):806-9.

Poglar K, Hill JA. Progesterone inhibits invitro embryotoxic factor production in women with recurrent sbontaneous abortion. Proc Soc Gynecol Invest. 1994;41:22-6.

Kuohung W, Hornstein MD, Barbieri RL, Barss VA. Evaluation of female infertility. www.uptodate.com Son erişim:10.10.2018

Choi BC, Polgar K, Xiao L, Hill JA. Progesterone inhibits in-vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod. 2000;15(suppl_1):46-59.

Ouzounian S, Bringer-Deutsch S, Jablonski C, Théron-Gérard L, Snaifer E, Cedrin-Durnerin I, et al. Hypothyroidism: from the desire for pregnancy to delivery. Gynecologie, Obstetrique & Fertilite. 2007;35(3):240-8.

Palomba S, Orio Jr F, Falbo A, Russo T, Tolino A, Zullo F. Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism. 2007;92(9):3498-503.

Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism. 2002;87(2):524-9.

Rushworth F, Backos M, Rai Ra, Chilcott I, Baxter N, Regan L. Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum Reprod. 2000;15(7):1637-9.

Esplin MS, Branch DW, Silver R, Stagnaro-Green A. Thyroid autoantibodies are not associated with recurrent pregnancy loss. American Journal of Obstetrics and Gynecology. 1998;179(6):1583-6.

Lazarus J, Premawardhana L. BEST PRACTICE NO 184 Screening for thyroid disease in pregnancy. Journal of Clinical Pathology. 2005;58(5):449-52.

Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, Canick J, Porter TF, et al. Maternal thyroid hypofunction and pregnancy outcome. Obstetrics and Gynecology. 2008;112(1):85.

Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod. 2002;17(11):2858-64.

Rai R, Backos M, Rushworth F, Regan L. Polycystic ovaries and recurrent miscarriage—a reappraisal. Hum Reprod. 2000;15(3):612-5.

Jakubowicz DJ, Seppälä M, Jakubowicz S, Rodriguez-Armas O, Rivas- Santiago A, Koistinen H, et al. Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism. 2001;86(3):1126-33.

Craig LB, Ke RW, Kutteh WH. Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss. Fertility and Sterility. 2002;78(3):487-90.

Glueck C, Phillips H, Cameron D, Sieve-Smith L, Wang P. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertility and Sterility. 2001;75(1):46-52.

Miodovnik M, Skillman C, Holroyde JC, Butler JB, Wendel JS, Siddiqi TA. Elevated maternal glycohemoglobin in early pregnancy and spontaneous abortion

among insulin-dependent diabetic women. American Journal of Obstetrics & Gynecology. 1985;153(4):439-42.

Dlugi AM. Hyperprolactinemic recurrent spontaneous pregnancy loss: a true clinical entity or a spurious finding? Fertility and Sterility. 1998;70(2):253-5.

Acien P, Acien M, Sanchez-Ferrer M. Complex malformations of the female genital tract. New types and revision of classification. Hum Reprod. 2004;19(10):2377-84.

Patton PE, Novy MJ. Reproductive potential of the anomalous uterus. Seminars in reproductive endocrinology. Thieme Medical Publishers. 1988; 6(2): 217-33.

Salim R, Regan L, Woelfer B, Backos M, Jurkovic D. A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. Hum Reprod. 2003;18(1):162-6.

Clifford K, Rai R, Watson H, Regan L. Pregnancy: An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod. 1994;9(7):1328-32.

Homer HA, Li T-C, Cooke ID. The septate uterus: a review of management and reproductive outcome. Hum Reprod. 2000;73(1):1-14.

Golan A, Langer R, Bukovsky I, Caspi E. Congenital anomalies of the müllerian system. Fertility and Sterility. 1989;51(5):747-55.

Vollenhoven BJ, Lawrence AS, Healy DL. Uterin fibroids: a clinical rewiev. Br J Obstet Gynaecol 1990; 97:285.

Pabuccu R, Atay V, Orhon E, Urman B, Ergun A. Hysteroscopic treatment of intrauterine adhesions is safe and effective in the restoration of normal menstruation and fertility. Fertility and Sterility. 1997;68(6):1141-3.

Paulson RJ. Hormonal induction of endometrial receptivity. Fertility and Sterility. 2011;96(3):530-5.

Matovina M, Husnjak K, Milutin N, Ciglar S, Grce M. Possible role of bacterial and viral infections in miscarriages. Fertility and Sterility. 2004;81(3):662- 9.

Ito K, Karasawa M, Kawano T. Involvement of decidual Valpha 14 NKT cells in abortion. Proc Natl Acad Sci U S A. 2009;97:740-4.

Lucas ES, Dyer NP, Murakami K, Lee YH, Chan YW, Grimaldi G, et al. Loss of endometrial plasticity in recurrent pregnancy loss. Stem Cells. 2016;34(2):346-56.

Kallen CB, Arici A. Immune testing in fertility practice: truth or deception? Current Opinion in Obstetrics and Gynecology. 2003;15(3):225-31.

Hill J, Choi B. Maternal immunological aspects of pregnancy success and failure. Journal of Reproduction and Fertility Supplement. 2000;55:91-7.

Obstetricians ACo, Gynecologists. ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001.(Replaces Technical Bulletin Number 212, September 1995). American College of Obstetricians and Gynecologists. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2002;78(2):179.

Dhont M. Recurrent miscarriage. Current Womens Health Reports. 2003;3(5):361-6.

Papazoglou D, Galazios G, Papatheodorou K, Liberis V, Papanas N, Maltezos E, et al. Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss. Fertility and Sterility. 2005;83(4):959-63.

Sotiriadis A, Makrigiannakis A, Stefos T, Paraskevaidis E, Kalantaridou SN. Fibrinolytic defects and recurrent miscarriage: a systematic review and meta- analysis. Obstetrics & Gynecology. 2007;109(5):1146-55.

Laude I, Rongieres-Bertrand C, Boyer-Neumann C, Wolf M, Mairovitz V, Hugel B, et al. Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight. Thrombosis and Haemostasis. 2001;85(01):18-21.

Tiscia G, Colaizzo D, Chinni E, Pisanelli D, Sciannamè N, Favuzzi G, et al. Haplotype M2 in the annexin A5 (ANXA5) gene and the occurrence of obstetric complications. Thrombosis and Haemostasis. 2009;101(02):309-13.

Bogdanova N, Horst J, Chlystun M, Croucher PJ, Nebel A, Bohring A, et al. A common haplotype of the annexin A5 (ANXA5) gene promoter is associated with recurrent pregnancy loss. Human Molecular Genetics. 2007;16(5):573-8.

Miyamura H, Nishizawa H, Ota S, Suzuki M, Inagaki A, Egusa H, et al. Polymorphisms in the annexin A5 gene promoter in Japanese women with recurrent pregnancy loss. Molecular Hum Reprod. 2011;17(7):447-52.

Rogenhofer N, Engels L, Bogdanova N, Tüttelmann F, Markoff A, Thaler C. Paternal and maternal carriage of the annexin A5 M2 haplotype are equal risk factors for recurrent pregnancy loss: a pilot study. Fertility and Sterility. 2012;98(2):383-8.

Karata S, Aydin Y, Ocer F, Buyru A, Balci H. Hereditary thrombophilia, anti‐ beta2 glycoprotein 1 IgM, and anti‐ annexin V antibodies in recurrent pregnancy loss. American Journal of Reproductive Immunology. 2012;67(3):251-5.

Rai R, Backos M, Elgaddal S, Shlebak A, Regan L. Factor V Leiden and recurrent miscarriage—prospective outcome of untreated pregnancies. Hum Reprod. 2002;17(2):442-5.

Sarig G, Vidergor G, Brenner B. Assessment and management of high risk pregnancies in women with thrombophilia Blood Reviews 2009; 23: 143-7.

Robertson L, Wu O, Langhorne P. The thrombosis: risk and economic assessment of thrombophilia screening (TREATS) study. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006;132:171-96.

Rai R, Shlebak A, Cohen H, Backos M, Holmes Z, Marriott K, et al. Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod. 2001;16(5):961-5.

Grandone E, Margaglione M, Colaizzo D, Pavone G, Paladini D, Martinelli P, et al. Lower birth-weight in neonates of mothers carrying factor V G1691A and factor II A (20210) mutations. Haematologica. 2002;87(2):177-81.

Kutteh WH, Park VM, Deitcher SR. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertility and Sterility. 1999;71(6):1048-53.

Foka Z, Lambropoulos A, Saravelos H, Karas G, Karavida A, Agorastos T, et al. Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Hum Reprod. 2000;15(2):458-62.

Finkelstein JD. Methionine metabolism in mammals: effects of age, diet, and hormones on three enzymes of the pathway in rat tissues. Archives of Biochemistry and Biophysics. 1967;122(3):583-90.

Raziel A, Friedler S, Schachter M, Ron‐ El R, Kornberg Y, Sela B. Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss. American Journal of Reproductive Immunology. 2001;45(2):65-71.

Walker MC, Smith GN, Perkins SL, Keely EJ, Garner PR. Changes in homocysteine levels during normal pregnancy. American Journal of Obstetrics and Gynecology. 1999;180(3):660-4.

Preston F, Rosendaal F, Walker I, Briet E, Berntorp E, Conard Ja, et al. Increased fetal loss in women with heritable thrombophilia. The Lancet. 1996;348(9032):913-6.

Tait R, Walker ID, Perry D, Islam S, Daly M, McCall F, et al. Prevalence of antithrombin deficiency in the healthy population. British Journal of Haematology. 1994;87(1):106-12.

Bellver J, Rossal LP, Bosch E, Zúñiga A, Corona JT, Meléndez F, et al. Obesity and the risk of spontaneous abortion after oocyte donation. Fertility and Sterility. 2003;79(5):1136-40.

Speroff L, Robert HG, Nathan GK. Recurrent Early Pregnancy Losses. Clinical Gynecologic Endocrinology and Infertility 6th ed. 1999 Lippincott Williams & Wilkins

Chatenoud L, Parazzini F, Di Cintio E, Zanconato G, Benzi G, Bortolus R, et al. Paternal and maternal smoking habits before conception and during the first trimester: relation to spontaneous abortion. Annals of Epidemiology. 1998;8(8):520- 6.

Kesmodel U, Wisborg K, Olsen SF, Brink Henriksen T, Jørgen Secher N. Moderate alcohol intake in pregnancy and the risk of spontaneous abortion. Alcohol and Alcoholism. 2002;37(1):87-92.

Choi TY, Lee HM, Park WK, Jeong SY, Moon HS. Spontaneous abortion and recurrent miscarriage: A comparison of cytogenetic diagnosis in 250 cases. Obstetrics & Gynecology Science. 2014;57(6):518-25.

Stephenson MD. Management of recurrent early pregnancy loss. The Journal of Reproductive Medicine. 2006;51(4):303-10.

Soares SR, dos Reis MMBB, Camargos AF. Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases. Fertility and Sterility. 2000;73(2):406-11.

Obstetricians ACo, Gynecologists. ACOG Committee Opinion No. 446: array comparative genomic hybridization in prenatal diagnosis. Obstet Gynecol. 2009;114(5):1161-3.

Goldberg J, Falcone T, Attaran M. Sonohysterographic evaluation of uterine abnormalities noted on hysterosalpingography. Human Reproduction (Oxford, England). 1997;12(10):2151-3.

Smit JG, Overdijkink S, Mol BW, Kasius JC, Torrance HL, Eijkemans MJ, et al. The impact of diagnostic criteria on the reproducibility of the hysteroscopic diagnosis of the septate uterus: a randomized controlled trial. Hum Reprod. 2015;30(6):1323-30.

Sersam LW. The Value of Transvaginal Sonography Performed before Diagnostic Hysteroscopy for the Evaluation of Uterine Cavity in Infertile Women. Iraqi Academic Scientific Journal. 2007;6(4):276-85.

Orazi C, Lucchetti MC, Schingo PM, Marchetti P, Ferro F. Herlyn-Werner- Wunderlich syndrome: uterus didelphys, blind hemivagina and ipsilateral renal agenesis. Sonographic and MR findings in 11 cases. Pediatric Radiology. 2007;37(7):657-65.

Caliskan E, Ozkan S, Cakiroglu Y, Sarisoy HT, Corakci A, Ozeren S. Diagnostic accuracy of real‐ time 3D sonography in the diagnosis of congenital Mullerian anomalies in high‐ risk patients with respect to the phase of the menstrual cycle. Journal of Clinical Ultrasound. 2010;38(3):123-7.

Bermejo C, Ten PM, Cantarero R, Diaz D, Pedregosa JP, Barrón E, et al. Three‐ dimensional ultrasound in the diagnosis of Müllerian duct anomalies and concordance with magnetic resonance imaging. Ultrasound in Obstetrics and Gynecology. 2010;35(5):593-601.

Branch DW, Porter TF, Paidas MJ, Belfort MA, Gonik B. Obstetric uses of intravenous immunoglobulin: successes, failures, and promises. Journal of Allergy and Clinical Immunology. 2001;108(4):S133-S8.

Carp H, Guetta E, Dorf H, Soriano D, Barkai G, Schiff E. Embryonic karyotype in recurrent miscarriage with parental karyotypic aberrations. Fertility and Sterility. 2006;85(2):446-50.

Gaboon NE, Mohamed AR, Elsayed SM, Zaki OK, Elsayed MA. Structural chromosomal abnormalities in couples with recurrent abortion in Egypt. Turkish Journal of Medical Sciences. 2015;45(1):208-13.

Carp H, Feldman B, Oelsner G, Schiff E. Parental karyotype and subsequent live births in recurrent miscarriage. Fertility and Sterility. 2004;81(5):1296-301.

Fritz B, Hallermann C, Olert J, Fuchs B, Bruns M, Aslan M, et al. Cytogenetic analyses of culture failures by comparative genomic hybridisation (CGH)–Re-evaluation of chromosome aberration rates in early spontaneous abortions. European Journal of Human Genetics. 2001;9(7):539.

Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A. Association between thyroid autoantibodies and miscarriage and preterm birth: meta- analysis of evidence. BMJ. 2011;342:d2616.

Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. The Journal of Clinical Endocrinology & Metabolism. 2010;95(9):E44-E8.

Trout SW, Seifer DB. Do women with unexplained recurrent pregnancy loss have higher day 3 serum FSH and estradiol values? Fertility and Sterility. 2000;74(2):335-7.

de Laat HB, Derksen RH, Urbanus RT, Roest M, de Groot PG. β2- glycoprotein I–dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome. Blood. 2004;104(12):3598-602.

Arnout JM, Vermylen J. Lupus anticoagulants: Mechanistic and diagnostic considerations. Hughes Syndrome: Springer; 2006. p. 291-306.

Vinatier D, Dufour P, Cosson M, Houpeau J. Antiphospholipid syndrome and recurrent miscarriages. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2001;96(1):37-50.

Cervera R, Balasch J. Autoimmunity and recurrent pregnancy losses. Clinical Reviews in Allergy & İmmunology. 2010;39(3):148-52.

Laird S, Tuckerman E, Cork B, Linjawi S, Blakemore A, Li T. A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod. 2003;9(2):163-74.

Clark DA. Is there any evidence for immunologically mediated or immunologically modifiable early pregnancy failure? Journal of Assisted Reproduction and Genetics. 2003;20(2):63-72.

McKnight K, McKenzie LJ. Evaluation of Infertility, Ovulation Induction and Assisted Reproduction. 2016:37-50

Yenice MG, Tuğcu V, Arş BDSKE. Tekrarlayan gebelik kayıplarında erkek kaynaklı nedenler ve tedavi yöntemleri. Androloji Bülteni.18(65):111-4.

Laurino MY, Bennett RL, Saraiya DS, Baumeister L, Doyle DL, Leppig K, et al. Genetic evaluation and counseling of couples with recurrent miscarriage: recommendations of the National Society of Genetic Counselors. Journal of Genetic Counseling. 2005;14(3):165-81.

Saxena SG, Desai K, Shewale L, Ranjan P. Pre-implantation genetic screening using fluorescence in situ hybridization in couples of Indian ethnicity: Is there a scope? Journal of Human Reproductive Sciences. 2014;7(1):25.

Otani T, Roche M, Mizuike M, Colls P, Escudero T, Munné S. Preimplantation genetic diagnosis significantly improves the pregnancy outcome of translocation carriers with a history of recurrent miscarriage and unsuccessful pregnancies. Reproductive Biomedicine Online. 2006;13(6):869-74.

Munné S, Cohen J, Sable D. Preimplantation genetic diagnosis for advanced maternal age and other indications. Fertility and Sterility. 2002;78(2):234-6.

Werlin L, Rodi I, DeCherney A, Marello E, Hill D, Munné S. Preimplantation genetic diagnosis as both a therapeutic and diagnostic tool in assisted reproductive technology. Fertility and Sterility. 2003;80(2):467-8.

Mastenbroek S, Twisk M, van Echten-Arends J, Sikkema-Raddatz B, Korevaar JC, Verhoeve HR, et al. In vitro fertilization with preimplantation genetic screening. New England Journal of Medicine. 2007;357(1):9-17.

Patton PE, Novy MJ, Lee DM, Hickok LR. The diagnosis and reproductive outcome after surgical treatment of the complete septate uterus, duplicated cervix and vaginal septum. American Journal of Obstetrics and Gynecology. 2004;190(6):1669-75.

Wong LF, Porter TF, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database of Systematic Reviews. 2014; 21(10);CD000112.

Hutton B, Sharma R, Fergusson D, Tinmouth A, Hebert P, Jamieson J, et al. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology. 2007;114(2):134-42.

Christiansen OB, Larsen EC, Egerup P, Lunoee L, Egestad L, Nielsen HS. Intravenous immunoglobulin treatment for secondary recurrent miscarriage: a randomised, double‐ blind, placebo‐ controlled trial. BJOG: An International Journal of Obstetrics & Gynaecology. 2015;122(4):500-8.

Marqusee E, Hill JA, Mandel SJ. Thyroiditis after pregnancy loss. The Journal of Clinical Endocrinology & Metabolism. 1997;82(8):2455-7.

Sugiura-Ogasawara M. Recurrent pregnancy loss and obesity. Best Practice & Research Clinical Obstetrics & Gynaecology. 2015;29(4):489-97.

Hirahara F, Andoh N, Sawai K, Hirabuki T, Uemura T, Minaguchi H. Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertility and Sterility. 1998;70(2):246-52.

Palomba S, Santagni S, La Sala GB. Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue? Journal of Ovarian Research. 2015;8(1):77.

Saccone G, Schoen C, Franasiak JM, Scott Jr RT, Berghella V. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials. Fertility and Sterility. 2017;107(2):430-8. e3.

Murugappan G, Shahine LK, Perfetto CO, Hickok LR, Lathi RB. Intent to treat analysis of in vitro fertilization and preimplantation genetic screening versus expectant management in patients with recurrent pregnancy loss. Hum Reprod. 2016;31(8):1668-74.

Tulandi T, Al-Frozan HM. Management of couples with recurrent pregnancy loss. https://www.uptodate.com/ Erişim tarihi: 01.10.2018.

Daya S. Evaluation and management of recurrent spontaneous abortion. Current Opinion in Obstetrics & Gynecology. 1996;8(3):188-92.

Katz VL, Kuller JA. Recurrent miscarriage. American Journal of Perinatology. 1994;11(6):386-97.

Clifford K, Rai R, Watson H, Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod. 1994;9(7):1328-32.

Ewington LJ, Tewary S, Brosens JJ. New insights into the mechanisms underlying recurrent pregnancy loss. Journal of Obstetrics and Gynaecology Research. 2018:1-8.

Sugiura-Ogasawara M, Ozaki Y, Sato T, Suzumori N, Suzumori K. Poor prognosis of recurrent aborters with either maternal or paternal reciprocal translocations. Fertility and Sterility. 2004;81(2):367-73.

Daya S, Stephenson MD. Frequency of factors associated with habitual abortion in 197 couples. Fertility and Sterility. 1996;66(1):24-9.

Brigham S, Conlon C, Farquharson R. A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod. 1999;14(11):2868-71.

Warburton D, Fraser FC. Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit. American Journal of Human Genetics. 1964;16(1):1.

Nelen W, Braat D. Selective karyotyping in repeated miscarriage. Nederlands Tijdschrift Voor Geneeskunde. 2007;151(15):848-9.

Hogge WA, Prosen TL, Lanasa MC, Huber HA, Reeves MF. Recurrent spontaneous abortion and skewed X-inactivation: is there an association? American Journal of Obstetrics and Gynecology. 2007;196(4):384. e1-. e8.

Onderoglu L, Baykal C, Al R, Demirtas E, Deren O, Gurgey A. High frequency of thrombophilic disorders in women with recurrent fetal miscarriage. Clinical and Experimental Obstetrics & Gynecology. 2006;33(1):50-4.

Fandom PA, Kilby MD. Genetic risk of reccurence, and genetic counselling

E. In: Risk pregnancy, managemet options. 4th. Ed. (Cheff Edt: James D.) Saunders. 2011;35-54.

Obut M. Tekrarlayan Gebelik Kayıplarında Etiyolojik Nedenlerin Değerledirilmesi. (Uzmanlık Tezi) Diyarbakır 2011.

Özdemir S, Balcı O, Göktepe H, Görkemli H, Taşçı E, Acar H. Tekrarlayan gebelik kaybı olan hastalarda trombofili mutasyon sıklığının değerlendirilmesi. Genel Tıp Derg. 2010;20(3)93-97.

Boztosun A, Kumru S, Gödekmerdan A. Rekürren spontan abortuslarda lenfosit subgrubları ve sitokinlern rolünün araştırılması. Fırat Üniversitesi Sağlık Bilimleri Tıp Derg. 2004;18(3):147-55.

Çot Ö, Çelen B, Bülbül M, Develioğlu OH. Tekrarlayan Gebelik Kayıplarında Bir Sonraki Gebeliğin Sonucu: Prognostik Faktörler. Uludağ Üniversitesi Tıp Fakültesi Dergisi. 2008;34(1):21-5.

Metwally M, Ong KJ, Ledger WL, Li TC. Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta- analysis of the evidence. Fertility and sterility. 2008;90(3):714-26.

Piccinni MP, Scaletti C, Mavilia C, Lazzeri E, Romagnani P, Natali I, et al. Production of IL-4 and leukemia inhibitory factor by T cells of the cumulus oophorus: a favorable microenvironment for pre-implantation embryo development. European Journal of Immunology. 2001;31(8):2431-7.

Api M. Tekrarlayan gebelik kayıplarının tanısı ve epidemiyolojisi. İn: Tekrarlayan gebelik kayıpları (Edtr:Kadanalı S.). Nobel kitapevi. İstanbul 2012:1-15.

Polat A, Açık Y, Gürateş B. Elazığ devlet hastanesi aile planlaması polikliniğine başvuran kadınların doğurganlık özellikleri ve kullandıkları aile planlaması yöntemleri. Turgut Özal Tıp Merkezi Dergisi 2000;7(3):260- 5.

Quenby SM, Farquharson RG. Predicting recurring miscarriage: what is important? Obstetrics and Gynecology. 1993;82(1):132-8.

Taşhan F. Tekrarlayan erken gebelik kayıplarında maternal trombofilıler. (Uzmanlık tezi) İstanbul 2007.

Armstrong BG, McDonald AD, Sloan M. Cigarette, alcohol, and coffee consumption and spontaneous abortion. American Journal of Public Health. 1992;82(1):85-7.

Popova S, Lange S, Probst C, Parunashvili N, Rehm J. Prevalence of alcohol consumption during pregnancy and Fetal Alcohol Spectrum Disorders among the general and Aboriginal populations in Canada and the United States. European Journal of Medical Genetics. 2017;60(1):32-48.

Harlap S, Shiono P. Alcohol, smoking, and incidence of spontaneous abortions in the first and second trimester. The Lancet. 1980;316(8187):173-6.

Brezina PR, Kutteh WH. Recurrent early pregnancy loss. Clinical Reproductive Medicine and Surgery: Springer; 2017. p. 269-88.

Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY. Prevalence of factor V G1691A (factor V‐ Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. American Journal of Hematology. 2002;71(4):300-5.

Floyd RL, Decoufle P, Hungerford DW. Alcohol use prior to pregnancy recognition. American Journal of Preventive Medicine. 1999;17(2):101-7.

Kline J, Stein Z, Shrout P, Susser M, Warburton D. Drinking during pregnancy and spontaneous abortion. The Lancet. 1980;316(8187):176-80.

Gaskins AJ, Rich-Edwards JW, Williams PL, Toth TL, Missmer SA, Chavarro JE. Prepregnancy Low to Moderate Alcohol Intake Is Not Associated with Risk of Spontaneous Abortion or Stillbirth–3. The Journal of Nutrition. 2015;146(4):799-805.

Matsuo H, Maruo T, Hayashi M, Mochizuki M. Modification of endocrine function of trophoblasts by thyroid hormone. Nihon Sanka Fujinka Gakkai zasshi. 1991;43(11):1533-8.

Duz SA. Recurrent Pregnancy Loss [Tekrarlayan Gebelik Kayıpları]. Medicine Science| International Medical Journal. 2016;5(2):606-22.

Okon MA, Laird SM, Tuckerman EM, Li T-C. Serum Androgen Levels in Women who Have Recurrent Miscarriages and their Correlation with Markers of Endometrial Function 1. Fertility and Sterility. 1998;69(4):682-90.

Bussen S, Sütterlin M, Steck T. Endocrine abnormalities during the follicular phase in women with recurrent spontaneous abortion. Hum Reprod. 1999;14(1):18- 20.

Tuckerman EM, Okon MA, Li T-C, Laird SM. Do androgens have a direct effect on endometrial function? An in vitro study. Fertility and Sterility. 2000;74(4):771-9.

Deniz R, Baykuş Y, Kavak EÇ. Tekrarlayan Erken Gebelik Kayıplarına Yaklaşım. Kafkas Tıp Bilimleri Derg. 2016(2):130-7.

Dönmez M, Şişli T, Atış A, Aydın Y. Spontan Abortus ve Tiroit Fonksiyonları. Perinatoloji Derg. 2005;13(2): 110-3.

Carp HJ, Meroni PL, Shoenfeld Y. Autoantibodies as predictors of pregnancy complications. Rheumatology 2008;47:6-8. .

Kaprara A, Krassas GE. Thyroid autoimmunity and miscarriage. Hormones (Athens). 2008;7(4):294-302.

Glinoer D, Soto MF, Bourdoux P, Lejeune B, Delange F, Lemone M, et al. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. The Journal of Clinical Endocrinology & Metabolism. 1991;73(2):421-7.

Li T, Spuijbroek MD, Tuckerman E, Anstie B, Loxley M, Laird S. Endocrinological and endometrial factors in recurrent miscarriage. BJOG: An International Journal of Obstetrics & Gynaecology. 2000;107(12):1471-9.

Wang P, Streicher P, Glueck CJ. Treatment of polycystic ovary syndrome with insulin-lowering agents. Expert Opinion on Pharmacotherapy. 2002;3(8):1177- 89.

Smith ML, Schust DJ. Endocrinology and recurrent early pregnancy loss. Seminars in Reproductive Medicine; 2011;29(6):482-90.

Daya S. Evidence-based management of recurrent miscarriage: optimal diagnostic protocol. International Congress Series; 2004;1266:318-27.

Sugiura-Ogasawara M. Recurrent Pregnancy Loss: Current Evidence and Clinical Guideline. Precision Medicine in Gynecology and Obstetrics: Springer; 2017. p. 151-64.

Dempsey MA, Flood K, Burke N, Fletcher P, Kirkham C, Geary MP, et al. Perinatal outcomes of women with a prior history of unexplained recurrent miscarriage. The Journal of Maternal-Fetal & Neonatal Medicine. 2015;28(5):522-5.

Baek KH. Aberrant gene expression associated with recurrent pregnancy loss. MHR: Basic Science of Reproductive Medicine. 2004;10(5):291-7.

Sugiura M. Pregnancy and delivery in protein C-deficiency. Current Drug Targets. 2005;6(5):577-83.

Thompson JS, Thompson MW. Genetics in Medicine. 4th ed. Philadelphia: Saunders, 1986:169.

Han J, Yan J. Treatment of ABO blood type incompatibility caused early abortion with traditional Chinese medicine. Chinese Journal of İntegrated Traditional and Western medicine. 1993;13(1):13-5.

Malekasgar AM. ABO blood group prevalence in spontaneously repeated abortion. Turk J Haematol. 2004;2004(21):181-7.

Atasü T, Şahmay Ş. Abortus. Jinekoloji, Nobel, 2. Baskı, İstanbul, 2001,(37): 533-45

Kişnişçi G, Durukan Ü, AG, Önderoğlu Ö. Rekürren abortus. Temel Kadın Hastalıkları ve Doğum Bilgisi, 1.Baskı, Güneş Kitabevi, Ankara. 1996:1312-8.

Alp M, Diclehan O. Tekrarlayan spontan abortusları olan çiftlerde genetik araştırmalar. Dicle Tıp Derg. 2006;33(2):71-80.

Dubey S, Chowdhury M, Prahlad B, Kumar V, Mathur R, Hamilton S, et al. Cytogenetic causes for recurrent spontaneous abortions–an experience of 742 couples (1484 cases). Indian Journal of Human Genetics. 2005;11(2):96-8.

De la Fuente-Cortés BE, Cerda-Flores RM, Dávila-Rodríguez MI, García- Vielma C, De la Rosa Alvarado RM, Cortés-Gutiérrez EI. Chromosomal abnormalities and polymorphic variants in couples with repeated miscarriage in Mexico. Reproductive Biomedicine Online. 2009;18(4):543-8.

Niroumanesh S, Mehdipour P, Farajpour A, Darvish S. A cytogenetic study of couples with repeated spontaneous abortions. Annals of Saudi Medicine. 2011;31(1):77.

Jaslow CR, Carney JL, Kutteh WH. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertility and Sterility. 2010;93(4):1234-43.

Larsen EC, Christiansen OB, Kolte AM, Macklon N. New insights into mechanisms behind miscarriage. BMC. 2013;11(1):154.

Matsuura T, Kobayashi T, Asahina T, Kanayama N, Terao T. Is factor XII deficiency related to recurrent miscarriage? Seminars in Thrombosis and Hemostasis; 2001. New York: 584-662.

American College of Obstericans and Gynecologists.Antifosfolipid syndrome.ACOG Educatinal Bulletin.Washigton DC,ACOG, 1998;1-10.

Zammiti W, Mtiraoui N, Mercier E, Abboud N, Saidi S, Mahjoub T, et al. Association of factor V gene polymorphisms (Leiden; Cambridge; Hong Kong and HR2 haplotype) with recurrent idiopathic pregnancy loss in Tunisia. Thrombosis and Haemostasis. 2006;95(04):612-7.

Roqué H, Paidas MJ, Funai EF, Kuczynski E, Lockwood CJ. Maternal thrombophilias are not associated with early pregnancy loss. Thrombosis and Haemostasis. 2004;92(02):290-5.

Altintas A, Pasa S, Akdeniz N, Cil T, Yurt M, Ayyildiz O, et al. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey. Annals of Hematology. 2007;86(10):727-31.

Aksoy M, Tek İ, Karabulut H, Berker B, Söylemez F. Habituel abortuslarda Faktör V Leiden ve Faktör II G20210A mutasyonu. Turkısh Journal of Haematology (supplement). 2004; 24(3):101-2.

Reznikoff-Etiévant M, Cayol V, Carbonne B, Robert A, Coulet F, Milliez J. Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage. British Journal of Obstetrics and Gynaecology. 2001;108(12):1251-4.

Hashimoto K, Shizusawa Y, Shimoya K, Ohashi K, Shimizu T, Azuma C, et al. The factor V Leiden mutation in Japanese couples with recurrent spontaneous abortion. Hum Reprod. 1999;14(7):1872-4.

Yusoff NM, Abdullah WZ, Ghazali S, Othman MS, Baba AA, Abdullah N, et al. The absence of factor V Leiden mutation in Malays with recurrent spontaneous abortions. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2002;42(2):164-6.

Dizon-Townson DS, Kinney S, Branch DW, Ward K. The factor V Leiden mutation is not a common cause of recurrent miscarriage. Journal of Reproductive İmmunology. 1997;34(3):217-23.

Grandone E, Margaglione M, Colaizzo D, d'Addedda M, Cappucci G, Vecchione G, et al. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thrombosis and Haemostasis. 1997;77(05):0822-4.

Grandone E, Margaglione M, Colaizzo D, D’Andrea G, Cappucci G, Brancaccio V, et al. Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. American Journal of Obstetrics and Gynecology. 1998;179(5):1324-8.

Tal J, Schliamser LM, Leibovitz Z, Ohel G, Attias D. A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure. Hum Reprod. 1999;14(6):1624-7.

Pihusch R, Hiller E, Buchholz T, Rogenhofer N, Hasbargen U, Thaler CJ, et al. Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester. American Journal of Reproductive Immunology. 2001;46(2):124-31.

Cohen D. Inherited thrombophilia and pregnancy: Complications, diagnosis, and treatment. American Biotechnology Laboratory. 2002:20(5):22-4.

Unfried G, Griesmacher A, Weismüller W, Nagele F, Huber JC, Tempfer CB. The C677T polymorphism of the methylenetetrahydrofolate reductase gene and idiopathic recurrent miscarriage. Obstetrics & Gynecology. 2002;99(4):614-9.

Saatçi Ç, Öner G, Taflfldemir fifi et al., Parental Karyotype and Genetic Markers for Thrombophilia in Recurrent Miscarriage,J Turkish-German Gynecol. 2008; 9(3):139-43.

Şahin Fİ, Ataç B, Yılmaz Z, Zeyneloğlu HB. Tekrarlayan Gebelik Kayıplarında Trombofili Mutasyon Sıklıkları. Erciyes Medical Journal/Erciyes Tip Derg. 2009;31(2):104-9.

Ren A, Wang J. Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis. Fertility and Sterility. 2006;86(6):1716-22.

Carp H, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod. 2002;17(6):1633-7.

Pauer H-U, Voigt-Tschirschwitz T, Hinney B, Burfeind P, Wolf C, Emons G, et al. Analyzes of three common thrombophilic gene mutations in German women with recurrent abortions. Acta Obstetricia et Gynecologica Scandinavica. 2003;82(10):942-7.

Gönüllü R. Tekrarlayan gebelik kaybı öyküsü olan hastalarda etyolojik faktörlerin analizi (Uzmanlık Tezi) Malatya 2013.

Wold ASD, Pham N, Arici A. Anatomic factors in recurrent pregnancy loss. Seminars in reproductive medicine; 2006: Copyright© 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. pp:25-32.

Patriarca A, Piccioni V, Gigante V, Parise G, Benedetto C. Recurrent spontaneous abortion. Etiologic factors. Panminerva Medica. 2000;42(2):105-8.

Alborzi S, Dehbashi S, Parsanezhad ME. Differential diagnosis of septate and bicornuate uterus by sonohysterography eliminates the need for laparoscopy. Fertility and Sterility. 2002;78(1):176-8.

Proctor JA, Haney AF. Recurrent first trimester pregnancy loss is associated with uterine septum but not with bicornuate uterus. Fertility and Sterility. 2003;80(5):1212-5.

Wallach EE, Schenker JG, Margalioth EJ. Intrauterine adhesions: an updated appraisal. Fertility and Sterility. 1982;37(5):593-610.